{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T19:11:29Z","timestamp":1784056289877,"version":"3.55.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000},"content-version":"vor","delay-in-days":171,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG031110"],"award-info":[{"award-number":["R01AG031110"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG051406"],"award-info":[{"award-number":["U01AG051406"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U54HD090256"],"award-info":[{"award-number":["U54HD090256"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Clinical"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.nicl.2021.102740","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T20:03:40Z","timestamp":1624565020000},"page":"102740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndrome"],"prefix":"10.1016","volume":"31","author":[{"given":"Matthew D.","family":"Zammit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana L.","family":"Tudorascu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Laymon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigan L.","family":"Hartley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Ellison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid H.","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beau M.","family":"Ances","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sterling C.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles K.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan N.","family":"Sabbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chester A.","family":"Mathis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Klunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin L.","family":"Handen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley T.","family":"Christian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nicl.2021.102740_b0005","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1046\/j.1471-4159.1994.62031062.x","article-title":"Down\u2019s Syndrome: Up-Regulation of \u03b2-Amyloid Protein Precursor and \u03c4 mRNAs and Their Defective Coordination","volume":"62","author":"Oyama","year":"1994","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.nicl.2021.102740_b0010","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1056\/NEJM198906013202203","article-title":"Amyloid A4 Protein and Its Precursor in Down\u2019s Syndrome and Alzheimer\u2019s Disease","volume":"320","author":"Rumble","year":"1989","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.nicl.2021.102740_b0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1192\/bjp.180.5.405","article-title":"Genetic and host factors for dementia in Down\u2019s syndrome","volume":"180","author":"Schupf","year":"2002","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.nicl.2021.102740_b0020","first-page":"703","article-title":"Alzheimer\u2019s disease in Down syndrome: An overlooked population for prevention trials","volume":"4","author":"Strydom","year":"2018","journal-title":"Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions"},{"key":"10.1016\/j.nicl.2021.102740_b0025","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/jir.12390","article-title":"A prospective 20-year longitudinal follow-up of dementia in persons with Down syndrome","volume":"61","author":"McCarron","year":"2017","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/j.nicl.2021.102740_b0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/jir.12074","article-title":"A prospective 14-year longitudinal follow-up of dementia in persons with Down syndrome","volume":"58","author":"McCarron","year":"2014","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/j.nicl.2021.102740_b0035","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3233\/JAD-170624","article-title":"Predictors of Age of Diagnosis and Survival of Alzheimer\u2019s Disease in Down Syndrome","volume":"61","author":"Sinai","year":"2018","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.nicl.2021.102740_b0040","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1001\/jamaneurol.2018.3616","article-title":"Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years","volume":"76","author":"Hithersay","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nicl.2021.102740_b0045","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jalz.2011.09.229","article-title":"Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B","volume":"8","author":"Handen","year":"2012","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/j.nicl.2021.102740_b0050","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and Biomarker Changes in Dominantly Inherited Alzheimer\u2019s Disease","volume":"367","author":"Bateman","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.nicl.2021.102740_b0055","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1523\/JNEUROSCI.0730-07.2007","article-title":"Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees","volume":"27","author":"Klunk","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.nicl.2021.102740_b0060","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archneur.65.4.540","article-title":"Carbon 11\u2013Labeled Pittsburgh Compound B Positron Emission Tomographic Amyloid Imaging in Patients With APP Locus Duplication","volume":"65","author":"Remes","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nicl.2021.102740_b0065","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/archneurol.2009.285","article-title":"High Striatal Amyloid \u03b2-Peptide Deposition Across Different Autosomal Alzheimer Disease Mutation Types","volume":"66","author":"Villemagne","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nicl.2021.102740_b0070","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jalz.2015.07.490","article-title":"The pattern of amyloid accumulation in the brains of adults with Down syndrome","volume":"12","author":"Annus","year":"2016","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/j.nicl.2021.102740_b0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neurobiolaging.2017.04.006","article-title":"Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline","volume":"56","author":"Cole","year":"2017","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.nicl.2021.102740_b0080","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1093\/brain\/awu173","article-title":"Cognitive functioning in relation to brain amyloid-\u03b2 in healthy adults with Down syndrome","volume":"137","author":"Hartley","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.nicl.2021.102740_b0085","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/WNL.0000000000001212","article-title":"Age dependence of brain \u03b2-amyloid deposition in Down syndrome","volume":"84","author":"Jennings","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2021.102740_b0090","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/archneurol.2011.36","article-title":"Using Positron Emission Tomography and Carbon 11\u2013Labeled Pittsburgh Compound B to Image Brain Fibrillar \u03b2-Amyloid in Adults With Down Syndrome: Safety, Acceptability, and Feasibility","volume":"68","author":"Landt","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nicl.2021.102740_b0095","article-title":"Imaging neurodegeneration in Down syndrome: brain templates for amyloid burden and tissue segmentation","author":"Lao","year":"2018","journal-title":"Brain Imaging and Behavior"},{"key":"10.1016\/j.nicl.2021.102740_b0100","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jalz.2015.05.013","article-title":"The effects of normal aging on amyloid-\u03b2 deposition in nondemented adults with Down syndrome as imaged by carbon 11\u2013labeled Pittsburgh compound B","volume":"12","author":"Lao","year":"2016","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/j.nicl.2021.102740_b0105","first-page":"654","article-title":"Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in Down syndrome: A deep-phenotyping case report","volume":"11","author":"Mak","year":"2019","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"10.1016\/j.nicl.2021.102740_b0110","first-page":"69","article-title":"Dissociation of Down syndrome and Alzheimer\u2019s disease effects with imaging","volume":"2","author":"Matthews","year":"2016","journal-title":"Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions"},{"key":"10.1016\/j.nicl.2021.102740_b0115","article-title":"The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer\u2019s disease biomarkers in down syndrome. Front","volume":"9","author":"Rafii","year":"2015","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.nicl.2021.102740_b0120","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3233\/JAD-170390","article-title":"PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI)","volume":"60","author":"Rafii","year":"2017","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.nicl.2021.102740_b0125","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jalz.2015.01.006","article-title":"Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer\u2019s dementia","volume":"11","author":"Sabbagh","year":"2015","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/j.nicl.2021.102740_b0130","first-page":"1","article-title":"Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented Down syndrome population","volume":"9","author":"Lao","year":"2017","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"10.1016\/j.nicl.2021.102740_b0135","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neurobiolaging.2018.09.030","article-title":"Comparison of longitudinal A\u03b2 in nondemented elderly and Down syndrome","volume":"73","author":"Tudorascu","year":"2019","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.nicl.2021.102740_b0140","article-title":"Amyloid accumulation in Down syndrome measured with amyloid load","volume":"12","author":"Zammit","year":"2020","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"10.1016\/j.nicl.2021.102740_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2018.04.011","article-title":"PET staging of amyloidosis using striatum","author":"Hanseeuw","year":"2018","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/j.nicl.2021.102740_b0270","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/1467-8721.ep10768783","article-title":"Statistical power analysis","volume":"1","author":"Cohen","year":"1992","journal-title":"Current Directions in Psychological Science"},{"key":"10.1016\/j.nicl.2021.102740_b0150","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jalz.2018.01.002","article-title":"Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer\u2019s disease from late-onset amyloid deposition","volume":"14","author":"Cohen","year":"2018","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/j.nicl.2021.102740_b0155","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","article-title":"Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study","volume":"76","author":"Hanseeuw","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nicl.2021.102740_b0160","doi-asserted-by":"crossref","first-page":"e1452","DOI":"10.1212\/WNL.0000000000005354","article-title":"Memory decline accompanies subthreshold amyloid accumulation","volume":"90","author":"Landau","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2021.102740_b0165","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1523\/JNEUROSCI.0485-18.2018","article-title":"Subthreshold Amyloid Predicts Tau Deposition in Aging","volume":"38","author":"Leal","year":"2018","journal-title":"J Neurosci"},{"key":"10.1016\/j.nicl.2021.102740_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2021.117728","article-title":"PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer\u2019s disease progression in Down syndrome","volume":"228","author":"Zammit","year":"2021","journal-title":"NeuroImage"},{"key":"10.1016\/j.nicl.2021.102740_b0180","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jalz.2012.11.008","article-title":"[18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer\u2019s disease","volume":"9","author":"Xia","year":"2013","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/j.nicl.2021.102740_b0185","first-page":"271","article-title":"Widespread brain tau and its association with ageing","volume":"141","author":"Lowe","year":"2018","journal-title":"Braak stage and Alzheimer\u2019s dementia. Brain"},{"key":"10.1016\/j.nicl.2021.102740_b0190","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","article-title":"Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories","volume":"18","author":"Braak","year":"1997","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.nicl.2021.102740_b0195","article-title":"Tau and A\u03b2 imaging, CSF measures, and cognition in Alzheimer\u2019s disease","author":"Brier","year":"2016833866","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.nicl.2021.102740_b0200","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.24546","article-title":"Tau positron emission tomographic imaging in aging and early Alzheimer disease","volume":"79","author":"Johnson","year":"2016","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.nicl.2021.102740_b0205","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/brain\/aww027","article-title":"Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease","volume":"139","author":"Ossenkoppele","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.nicl.2021.102740_b0210","article-title":"Relationship of amyloid beta and neurofibrillary tau deposition in Neurodegeneration in Aging Down Syndrome (NiAD) study at baseline","volume":"6","author":"Tudorascu","year":"2020","journal-title":"Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions"},{"key":"10.1016\/j.nicl.2021.102740_b0215","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/S0140-6736(20)30689-9","article-title":"Clinical and biomarker changes of Alzheimer\u2019s disease in adults with Down syndrome: a cross-sectional study","volume":"395","author":"Fortea","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.nicl.2021.102740_b0175","doi-asserted-by":"crossref","unstructured":"Whittington, A., Gunn, RN. Amyloid Load \u2013 a more sensitive biomarker for amyloid imaging. J Nucl Med 2018. doi: 10.2967\/jnumed.118.210518.","DOI":"10.2967\/jnumed.118.210518"},{"key":"10.1016\/j.nicl.2021.102740_b0220","doi-asserted-by":"crossref","unstructured":"Handen BL, Lott IT, Christian BT, Schupf N, OBryant S, Mapstone M, et al. The Alzheimer\u2019s Biomarker Consortium-Down Syndrome: Rationale and methodology. Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring 2020;12:e12065. 10.1002\/dad2.12065.","DOI":"10.1002\/dad2.12065"},{"key":"10.1016\/j.nicl.2021.102740_b0225","series-title":"Peabody picture vocabulary test","author":"Dunn","year":"2007"},{"key":"10.1016\/j.nicl.2021.102740_b0230","article-title":"Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer\u2019s disease in Down syndrome","volume":"12","author":"Hartley","year":"2020","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"10.1016\/j.nicl.2021.102740_b0235","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1016\/j.nicl.2021.102740_b0240","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1212\/01.wnl.0000172958.95282.2a","article-title":"The AD8: A brief informant interview to detect dementia","volume":"65","author":"Galvin","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2021.102740_b0245","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1212\/01.wnl.0000247042.15547.eb","article-title":"Validity and reliability of the AD8 informant interview in dementia","volume":"67","author":"Galvin","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2021.102740_b0250","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ridd.2013.11.016","article-title":"Matching variables for research involving youth with Down syndrome: Leiter-R versus PPVT-4","volume":"35","author":"Phillips","year":"2014","journal-title":"Research in Developmental Disabilities"},{"key":"10.1016\/j.nicl.2021.102740_b0255","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","article-title":"PET Imaging of Tau Deposition in the Aging Human Brain","volume":"89","author":"Sch\u00f6ll","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.nicl.2021.102740_b0260","first-page":"904","article-title":"Correction for partial volume effects in PET: Principle and validation","volume":"39","author":"Rousset","year":"1998","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.nicl.2021.102740_b0265","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.dib.2017.10.024","article-title":"Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data","volume":"15","author":"Baker","year":"2017","journal-title":"Data in Brief"},{"key":"10.1016\/j.nicl.2021.102740_b0275","series-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.nicl.2021.102740_b0280","unstructured":"Rafii MS, Zaman S, Handen BL. Integrating Biomarker Outcomes into Clinical Trials for Alzheimer\u2019s Disease in Down Syndrome. J Prev Alzheimers Dis 2020. 10.14283\/jpad.2020.35."},{"key":"10.1016\/j.nicl.2021.102740_b0285","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3233\/JAD-170720","article-title":"Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-\u03b2 Burden in Down Syndrome","volume":"61","author":"Lao","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.nicl.2021.102740_b0290","article-title":"Patterns of glucose hypometabolism in Down syndrome resemble sporadic Alzheimer\u2019s disease except for the putamen","volume":"12","author":"Zammit","year":"2020","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"10.1016\/j.nicl.2021.102740_b0295","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2021.102740_b0300","article-title":"The AT(N) framework for Alzheimer\u2019s disease in adults with Down syndrome","volume":"12","author":"Rafii","year":"2020","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"10.1016\/j.nicl.2021.102740_b0305","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1093\/brain\/awz268","article-title":"The bivariate distribution of amyloid-\u03b2 and tau: relationship with established neurocognitive clinical syndromes","volume":"142","author":"Jack","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.nicl.2021.102740_b0310","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/brain\/aww023","article-title":"Regional profiles of the candidate tau PET ligand 18 F-AV-1451 recapitulate key features of Braak histopathological stages","volume":"139","author":"Schwarz","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.nicl.2021.102740_b0315","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13195-019-0468-1","article-title":"Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer\u2019s disease","volume":"11","author":"Hanseeuw","year":"2019","journal-title":"Alz Res Therapy"},{"key":"10.1016\/j.nicl.2021.102740_b0320","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11682-018-9847-7","article-title":"PET imaging of tau protein targets: a methodology perspective","volume":"13","author":"Lois","year":"2019","journal-title":"Brain Imaging and Behavior"},{"key":"10.1016\/j.nicl.2021.102740_b0325","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/mds.26813","article-title":"Increased basal ganglia binding of 18 F-AV-1451 in patients with progressive supranuclear palsy","volume":"32","author":"Smith","year":"2017","journal-title":"Mov Disord"},{"key":"10.1016\/j.nicl.2021.102740_b0330","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13195-019-0470-7","article-title":"18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes","volume":"11","author":"Tsai","year":"2019","journal-title":"Alz Res Therapy"},{"key":"10.1016\/j.nicl.2021.102740_b0335","first-page":"21","article-title":"Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition","volume":"6","author":"Vemuri","year":"2017","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"10.1016\/j.nicl.2021.102740_b0340","article-title":"What is T+? A Gordian Knot of Tracers, Thresholds & Topographies","author":"Villemagne","year":"2020","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.nicl.2021.102740_b0345","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13195-019-0478-z","article-title":"Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers","volume":"11","author":"Salvad\u00f3","year":"2019","journal-title":"Alzheimer\u2019s Research & Therapy"},{"key":"10.1016\/j.nicl.2021.102740_b0350","doi-asserted-by":"crossref","unstructured":"Mattsson-Carlgren N, S J, R B, R S, E S, G S, et al. Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau 2021. 10.21203\/rs.3.rs-101153\/v2.","DOI":"10.21203\/rs.3.rs-101153\/v2"}],"container-title":["NeuroImage: Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158221001844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158221001844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:34:21Z","timestamp":1761971661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213158221001844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":70,"alternative-id":["S2213158221001844"],"URL":"https:\/\/doi.org\/10.1016\/j.nicl.2021.102740","relation":{},"ISSN":["2213-1582"],"issn-type":[{"value":"2213-1582","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndrome","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nicl.2021.102740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102740"}}